AGENEBIO, INC.

Profile

Company Names

AGENEBIO, INC.

Addresses

1101 E. 33RD STREET, SUITE C310, BALTIMORE, MD 21218

601 S. CHARLES STREET, BALTIMORE, MD 21230

11711 NORTH MERIDIAN STREET, SUITE 520, CARMEL, IN 46032

11711 NORTH MERIDIAN STREET, SUITE #520, CARMEL, IN 46032

11711 N. MERIDIAN STREET, SUITE 520, CARMEL, IN 46032

800 E. 96TH STREET, SUITE 135, INDIANAPOLIS, IN 46240

351 WEST 10TH STREET, INDIANAPOLIS, IN 46202

WEST 351 10TH STREET, INDIANAPOLIS, IN 46202

Phone Numbers

410-685-3000
317-816-9325
317-278-4835
317-224-9736
317-294-8035

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$11,501,926.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2016-07-26 
$500,076.00 
$3,000,000.00 
$2,499,924.00 
Equity 
8
2015-01-26 
$400,000.00 
$900,000.00 
$500,000.00 
Debt 
7
2014-10-03 
$4,113,127.00 
$10,000,000.00 
$5,886,873.00 
Equity 
6
2013-11-04 
$1,000,113.00 
$3,300,000.00 
$2,299,887.00 
Equity 
5
2013-05-22 
$1,000,000.00 
$4,000,000.00 
$3,000,000.00 
Equity 
4
2012-09-14 
$450,000.00 
$975,000.00 
$525,000.00 
Debt 
3
2010-10-01 
$3,688,610.00 
$5,000,000.00 
$1,311,390.00 
Debt 
2
2010-04-05 
$300,000.00 
$300,000.00 
$0.00 
Debt 
1
2009-06-30 
$50,000.00 
INDEFINITE 
INDEFINITE 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FLOYD 
 
BLOOM 
DIRECTOR
CHARLES 
 
CLARVIT 
DIRECTOR
MICHELA 
 
GALLAGHER 
EXECUTIVE OFFICER, DIRECTOR
PATRICK 
 
LEPORE 
DIRECTOR
GERALD 
W. 
MCLAUGHLIN 
EXECUTIVE OFFICER, DIRECTOR
RONALD 
 
NORDMANN 
DIRECTOR
TIMOTHY 
F. 
PARSHALL 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
POSTLETHWAIT 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
 
RINGO 
DIRECTOR
SHARON 
 
ROSENZWEIG-LIPSON 
EXECUTIVE OFFICER
KRISTIN 
 
SHERMAN 
EXECUTIVE OFFICER
GARDINER 
 
SMITH 
EXECUTIVE OFFICER, DIRECTOR
BRIAN 
 
STEMME 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-01-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-11-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-22 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2012-09-14 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2010-10-01 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2010-10-01 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2010-10-01 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2010-10-01 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2010-04-05 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2009-06-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#